103 related articles for article (PubMed ID: 23403246)
1. Pharmacological comparison of peristaltic effects in rats and mice.
Shaughnessy TK; Larson KJ; Polakowski JS; Martin RL
J Pharmacol Toxicol Methods; 2013; 67(3):129-33. PubMed ID: 23403246
[TBL] [Abstract][Full Text] [Related]
2. [The employment of pharmacodynamic tests in the radiological examination of the digestive tract (author's transl)].
Renda F; Lupini A; Bonomo L; Basilico L
Radiol Med; 1978 Dec; 64(12):1345-51. PubMed ID: 754203
[TBL] [Abstract][Full Text] [Related]
3. New methods to detect the effect of alteration in gastric pH and intestinal transit by metoclopramide and propantheline using a continuous gastric pH probe and hydrogen breath analysis.
Hughes GS; VanderLugt JT; Bays M; Bohan DF; Francom SF
Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):155-60. PubMed ID: 2319840
[TBL] [Abstract][Full Text] [Related]
4. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.
Bianchi G; Ferretti P; Recchia M; Rocchetti M; Tavani A; Manara L
Gastroenterology; 1983 Oct; 85(4):852-8. PubMed ID: 6193028
[TBL] [Abstract][Full Text] [Related]
5. Effects of fasting on evaluation of gastrointestinal transit with charcoal meal.
Mittelstadt SW; Hemenway CL; Spruell RD
J Pharmacol Toxicol Methods; 2005; 52(1):154-8. PubMed ID: 15963735
[TBL] [Abstract][Full Text] [Related]
6. The influence of codeine, propantheline and metoclopramide on small bowel transit and theophylline absorption from a sustained-release formulation.
Sommers DK; Meyer EC; Van Wyk M; Moncrieff J; Snyman JR; Grimbeek RJ
Br J Clin Pharmacol; 1992 Mar; 33(3):305-8. PubMed ID: 1576052
[TBL] [Abstract][Full Text] [Related]
7. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
[TBL] [Abstract][Full Text] [Related]
8. Effect of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of the rat.
Weisbrodt NW; Sussman SS; Stewart JJ; Burks TF
J Pharmacol Exp Ther; 1980 Aug; 214(2):333-8. PubMed ID: 7391981
[TBL] [Abstract][Full Text] [Related]
9. Morphine tolerance and dependence in the rat intestine in vivo.
Williams CL; Bihm CC; Rosenfeld GC; Burks TF
J Pharmacol Exp Ther; 1997 Feb; 280(2):656-63. PubMed ID: 9023276
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
Manara L; Bianchi G; Ferretti P; Tavani A
J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
[TBL] [Abstract][Full Text] [Related]
11. Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine.
Fiocchi R; Bianchi G; Petrillo P; Tavani A; Manara L
Life Sci; 1982 Nov 15-22; 31(20-21):2221-3. PubMed ID: 7162339
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic determination of the effect of metoclopramide and morphine on small intestinal transit time.
Prokop EK; Caride VJ; Winchenbach K; Troncale FJ; McCallum RW
Am J Physiol Imaging; 1988; 3(4):201-4. PubMed ID: 3063306
[TBL] [Abstract][Full Text] [Related]
13. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
14. Influence of prokinetics on the gastrointestinal transit and residence times of activated charcoal.
Orisakwe OE; Afonne OJ; Ilondu NA; Obi E; Ufearo CS; Agbasi PU; Maduka SO; Orish CN; Orish VN
J Pak Med Assoc; 2002 Aug; 52(8):354-6. PubMed ID: 12481675
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability.
Marks L; Beard E; Cobey D; Moore N; Motyer V; Valentin JP; Ewart L
J Pharmacol Toxicol Methods; 2013; 68(1):123-36. PubMed ID: 23542059
[TBL] [Abstract][Full Text] [Related]
16. [Effect of ghrelin on small intestinal transit and interdigestive gastrointestinal migrating myoelectric complex in rats].
Wang Y; Dong L; Zhao P; Cheng Y; Li HP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):328-32. PubMed ID: 18359683
[TBL] [Abstract][Full Text] [Related]
17. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
Galligan JJ; Burks TF
J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
[TBL] [Abstract][Full Text] [Related]
18. Intestinal lead absorption in rats: effects of circadian rhythm, food, undernourishment, and drugs which alter gastric emptying and GI motility.
Aungst BJ; Fung HL
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):515-30. PubMed ID: 7323447
[TBL] [Abstract][Full Text] [Related]
19. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.
Marathe PH; Wen Y; Norton J; Greene DS; Barbhaiya RH; Wilding IR
Br J Clin Pharmacol; 2000 Oct; 50(4):325-32. PubMed ID: 11012555
[TBL] [Abstract][Full Text] [Related]
20. Obstructive cholestasis alters intestinal transit in mice: role of opioid system.
Ghaffari K; Savadkuhi ST; Honar H; Riazi K; Shafaroodi H; Moezi L; Ebrahimkhani MR; Tahmasebi MS; Dehpour AR
Life Sci; 2004 Dec; 76(4):397-406. PubMed ID: 15530502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
